Position in LH
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$84,236,880
+$10,295,025 QoQ
Shares Held
300,846
+8.6% QoQ
Ownership
0.371%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#50
of 1,040 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Pacer Advisors, Inc. holds $369,664,886 across 21 Diagnostics & Research names. LH ranks #2 (22.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IQV |
Iqvia Holdings Inc.
|
668,811 | $129,227,661 | |
| 2 | LH |
Labcorp Holdings Inc.
This page
|
300,846 | $84,236,880 | |
| 3 | DGX |
Quest Diagnostics Inc
|
381,995 | $80,963,840 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
33,719 | $17,751,030 | |
| 5 | MEDP |
Medpace Holdings, Inc.
|
31,102 | $16,471,308 | |
| 6 | TMO |
Thermo Fisher Scientific Inc.
|
29,281 | $14,680,322 | |
| 7 | DHR |
Danaher Corp /De/
|
50,016 | $9,527,047 | |
| 8 | CRL |
Charles River Laboratories International, Inc.
|
13,557 | $3,074,592 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $84,236,880 | 300,846 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $73,941,855 | 277,133 | Shares | Sole | 2026-06-18 | |
| 2025-12-31 | $78,701,557 | 313,702 | Shares | Sole | 2026-02-24 | |
| 2025-09-30 | $87,767,446 | 305,746 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $1,924,460 | 7,331 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,001,480 | 4,303 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $1,542,864 | 6,728 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $5,672,369 | 25,382 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,988,388 | 19,598 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||